Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Parts I and III Total Score

Mentation, behaviour and mood is scored from 0-16 in UPDRS I (0 = best score to 16 = worst score), result of motor examination scored from 0-108 in UPDRS III (0=no disability, 108=maximum disability) . The change was calculated by Baseline value minus value at visit 3. A decrease (change\>0) in the score means improvement.

Time frame: Baseline and the end of study (up to 16 weeks)

Clinical Global Impression of Improvement (CGI-I) Responder Rate

The CGI-I was rated (from 1: very much improved, to 7: very much worse) to assess the overall status of Parkinson's disease. The clinician rated how much a patient's condition had improved or worsened relative to baseline state. The patients are considered to be a CGI-I responder if they are rated at least by minimally improved.

Time frame: Baseline and the end of study (up to 16 weeks)

Change From Baseline in Visual Analogue Scale (VAS) of Patient Satisfaction

The visual analogue scale measures overall patient satisfaction with treatment on a continuous axis ranging from 0 (no satisfaction) to 100 (highest patient satisfaction). The change was calculated by the value at the final visit minus the value at baseline. Therefore, an increase (change\>0) reflects an improvement in patient satisfaction.

Time frame: Baseline and the end of study (up to 16 weeks)